Likewise, in the tumor microenvironment, the interaction of the PD-1 on tumor infiltrating T cells (TILs) with its ligands, PD-L1 and/or PD-L2 on the surface of antigen presenting cells and malignant cells inhibits TIL potency (Figure 1). Here, PDCD1 is linked to neoplasm.